Cancer Family
Breast Neoplasm
CI-CAN-00000007Explore in graph →
Non-malignant2,894 active trials43 approved drugs310 evidence items
- NCIt
- C2910
- OncoTree
- BNNOS
- MeSH
- D000069584
- MeSH
- D001943
Loading cancer entity…
Loading cancer entity…
Cancer Family
CI-CAN-00000007Explore in graph →
Clinical trials
13,871 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT00749437 | Radiation Therapy Using Gold Markers in Treating Women With Early-Stage Breast Cancer | completed | Phase 1 | 34 | University of Medicine and Dentistry of New JerseyOTHER | 1 | Jun 14, 2012 | clinicaltrials |
| NCT01372917 | Evaluating AlloMax in Immediate Expander-Based Breast Reconstruction Study | completed | — | 39 | National Center for Plastic Surgery, VirginiaOTHER | 1 | Jun 13, 2012 |
| clinicaltrials |
| NCT00004172 | Chemotherapy, Filgrastim, and Stem Cell Transplantation With Radiation Therapy in Treating Patients With Stage III or Stage IV Breast Cancer | completed | Phase 2 | — | Northwestern UniversityOTHER | 1 | Jun 12, 2012 | clinicaltrials |
| NCT00412412 | CNF2024 (BIIB021) HER2- (QD) HER2+ (BIW w/Herceptin) PK/PD Study | completed | Phase 1 | 34 | BiogenINDUSTRY | 1 | Jun 8, 2012 | clinicaltrials |
| NCT00006459 | Paclitaxel With or Without Gemcitabine in Treating Women With Advanced Breast Cancer | completed | Phase 3 | — | Eli Lilly and CompanyINDUSTRY | 1 | Jun 7, 2012 | clinicaltrials |
| NCT01613352 | Feasibility of Ambulatory Surgery for Early Breast Cancer | completed | N/A | 100 | Helsinki University Central HospitalOTHER | 1 | Jun 7, 2012 | clinicaltrials |
| NCT00004175 | Docetaxel, Doxorubicin, and Cyclophosphamide in Treating Women With Stage III Breast Cancer | completed | Phase 2 | — | Northwestern UniversityOTHER | 1 | Jun 6, 2012 | clinicaltrials |
| NCT00004182 | Irinotecan in Treating Patients With Metastatic or Recurrent Breast Cancer | completed | Phase 2 | — | Northwestern UniversityOTHER | 1 | Jun 6, 2012 | clinicaltrials |
| NCT00006225 | Peripheral Stem Cell Transplantation in Treating Patients With Breast Cancer or Hematologic Cancer | completed | Phase 1 / Phase 2 | — | Northwestern UniversityOTHER | 1 | Jun 6, 2012 | clinicaltrials |
| NCT00241449 | A Trial Comparing the Efficacy and Tolerability of Faslodex With Nolvadex in Postmenopausal Women With Advanced Breast Cancer | completed | Phase 3 | 51 | AstraZenecaINDUSTRY | 26 | Jun 6, 2012 | clinicaltrials |
| NCT00692289 | Quality of Life Analysis of Arimidex Treatment in Postmenopausal Patients With Breast Cancer(RADAR II E) | completed | — | 1,510 | AstraZenecaINDUSTRY | 1 | Jun 6, 2012 | clinicaltrials |
| NCT00849030 | ATAC - Arimidex, Tamoxifen Alone or in Combination | completed | Phase 3 | 9,358 | AstraZenecaINDUSTRY | 0 | Jun 6, 2012 | clinicaltrials |
| NCT00347568 | BC-DAISY: A Breast Cancer Decision Aid System | completed | N/A | 195 | Rhode Island HospitalOTHER | 1 | Jun 5, 2012 | clinicaltrials |
| NCT00162929 | Her-2/Neu in Patients With Metastatic Breast Cancer (AdHERe)(AdHERe) | completed | Phase 1 | 5 | Ontario Clinical Oncology Group (OCOG)OTHER | 0 | Jun 4, 2012 | clinicaltrials |
| NCT00307229 | Adenovirus Encoding Rat HER-2 in Patients With Metastatic Breast Cancer (AdHER2.1) | completed | Phase 1 | 8 | Ontario Clinical Oncology Group (OCOG)OTHER | 1 | Jun 4, 2012 | clinicaltrials |
| NCT01111201 | International Travel Patterns and Risk Behaviour of Breast Cancer, Lymphoma Patients and Bone Marrow Transplant Recipients | completed | — | 26 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Jun 1, 2012 | clinicaltrials |
| NCT00084344 | Effect of 4-Hydroxytamoxifen Gel on Breast Density, Salivary Sex Steroids, and Quality of Life in Premenopausal Women | completed | N/A | — | Northwestern UniversityOTHER | 1 | May 30, 2012 | clinicaltrials |
| NCT00538525 | Phase II Study of Neoadjuvant Chemotherapy With Doxorubicin Followed by Docetaxel-Cisplatin in Locally Advanced Breast Cancer | completed | N/A | 10 | King Faisal Specialist Hospital & Research CenterOTHER | 0 | May 30, 2012 | clinicaltrials |
| NCT00588614 | High Risk Screening Breast MR Using a Rapid Imaging Exam | completed | — | 140 | Mayo ClinicOTHER | 1 | May 30, 2012 | clinicaltrials |
| NCT00031811 | Raloxifene With or Without Exercise Compared With Exercise Alone in Women Who Have Been Previously Treated for Breast Cancer | completed | N/A | 80 | OHSU Knight Cancer InstituteOTHER | 1 | May 28, 2012 | clinicaltrials |
| NCT00135018 | Study on the Neoadjuvant Use of Chemotherapy and Celecoxib Therapy in Patients With Invasive Breast Cancer | completed | Phase 2 | — | Organisation for Oncology and Translational ResearchOTHER | 1 | May 24, 2012 | clinicaltrials |
| NCT00048633 | Phase II Study to Evaluate Tariquidar (XR9576), a Selective MDR-1 Inhibitor, in Chemotherapy Resistant Advanced Breast Cancer | completed | Phase 2 | 30 | QLT Inc.INDUSTRY | 1 | May 23, 2012 | clinicaltrials |
| NCT00237627 | Doxorubicin Hydrochloride Liposome and Bortezomib in Treating Patients With Refractory Hematologic Cancer or Malignant Solid Tumor or Metastatic Breast Cancer | completed | Phase 1 / Phase 2 | 107 | UNC Lineberger Comprehensive Cancer CenterOTHER | 1 | May 18, 2012 | clinicaltrials |
| NCT00287040 | Breast Cancer Screening Via Computer V. Phone | completed | Phase 3 | 1,686 | Indiana UniversityOTHER | 1 | May 17, 2012 | clinicaltrials |
| NCT00004046 | Chemotherapy in Treating Women With Metastatic Breast Cancer | completed | Phase 2 | — | Daiichi SankyoINDUSTRY | 1 | May 16, 2012 | clinicaltrials |
| NCT00286819 | Dose Density FU 75 and FU 90 as Adjuvant Therapy for Early Breast Cancer | completed | Phase 2 | 50 | Central European Cooperative Oncology GroupOTHER | 4 | May 16, 2012 | clinicaltrials |
| NCT00003902 | Capecitabine and Vinorelbine in Treating Older Women Who Have Metastatic Breast Cancer With or Without Bone Involvement | completed | Phase 1 / Phase 2 | 110 | Swiss Cancer InstituteOTHER | 1 | May 15, 2012 | clinicaltrials |
| NCT00031876 | Capecitabine and Paclitaxel in Treating Patients With Metastatic Breast Cancer | completed | Phase 1 / Phase 2 | 34 | Swiss Cancer InstituteOTHER | 1 | May 15, 2012 | clinicaltrials |
| NCT00708903 | Study to Examine the Effect of HKI-272 on Rhythms of the Heart (Cardiac Repolarization) | completed | Phase 1 | 60 | Puma Biotechnology, Inc.INDUSTRY | 1 | May 14, 2012 | clinicaltrials |
| NCT00251472 | A Phase II Trial of Abraxane™ Given Weekly as a Single Agent in First-line Treatment of Metastatic Breast Cancer | completed | Phase 2 | 72 | Veeda OncologyOTHER | 1 | May 11, 2012 | clinicaltrials |
| NCT00768859 | Trastuzumab in a Neo-adjuvant Regimen for HER2+ Breast Cancer - the TRAIN Study(TRAIN) | completed | Phase 2 | 111 | The Netherlands Cancer InstituteOTHER | 1 | May 11, 2012 | clinicaltrials |
| NCT00436410 | Tumor Necrosis Factor in Patients Undergoing Surgery for Primary Cancer or Metastatic Cancer | completed | Early Phase 1 | 108 | National Institutes of Health Clinical Center (CC)NIH | 1 | May 2, 2012 | clinicaltrials |
| NCT00467727 | Visibility of Lesion Characteristics With Phase Contrast Mammography | completed | N/A | 53 | UNC Lineberger Comprehensive Cancer CenterOTHER | 1 | May 1, 2012 | clinicaltrials |
| NCT01587248 | Use of Harmonic in Breast Surgery(HMRM) | completed | Phase 3 | 152 | Aga Khan UniversityOTHER | 1 | Apr 30, 2012 | clinicaltrials |
| NCT00083278 | Study of MDX-010 in Stage IV Breast Cancer | completed | Phase 2 | 33 | Bristol-Myers SquibbINDUSTRY | 1 | Apr 27, 2012 | clinicaltrials |
| NCT00467012 | Phase Ⅱ Clinical Study of R435 (Bevacizumab) in Combination With Paclitaxel in Patients With Inoperable Metastatic Breast Cancer | completed | Phase 2 | 122 | Chugai PharmaceuticalINDUSTRY | 1 | Apr 26, 2012 | clinicaltrials |
| NCT00247663 | Extension Study of 1.0mg Dose Letrozole Therapy in Postmenopausal Patients With Breast Cancer | completed | Phase 2 | 17 | Novartis PharmaceuticalsINDUSTRY | 1 | Apr 19, 2012 | clinicaltrials |
| NCT00171340 | Zoledronic Acid in the Prevention of Cancer Treatment Related Bone Loss in Postmenopausal Women Receiving Letrozole for Breast Cancer. | completed | Phase 3 | 1,065 | Novartis PharmaceuticalsINDUSTRY | 28 | Apr 16, 2012 | clinicaltrials |
| NCT00816244 | Study of Statin as Neo-Adjuvant Therapy in Postmenopausal Breast Cancer | completed | Phase 2 | 50 | Lund University HospitalOTHER | 1 | Apr 13, 2012 | clinicaltrials |
| NCT01236417 | Exercise Intervention in Breast Cancer Patients With Treatment-Induced Arthralgia | completed | N/A | 27 | Roswell Park Cancer InstituteOTHER | 1 | Apr 13, 2012 | clinicaltrials |
| NCT01577420 | Reflexology: An Intervention for Advanced Breast Cancer | completed | N/A | 451 | Michigan State UniversityOTHER | 1 | Apr 13, 2012 | clinicaltrials |
| NCT00171314 | The Use of Zoledronic Acid to Prevent Cancer-treatment Bone Loss in Post-menopausal Women Receiving Adjuvant Letrozole for Breast Cancer | completed | Phase 3 | 527 | Novartis PharmaceuticalsINDUSTRY | 9 | Apr 11, 2012 | clinicaltrials |
| NCT00375427 | Safety and Efficacy of Zoledronic Acid in Patients With Breast Cancer With Metastatic Bone Lesions | completed | Phase 3 | 430 | Novartis PharmaceuticalsINDUSTRY | 1 | Apr 11, 2012 | clinicaltrials |
| NCT01208480 | Bevacizumab, Docetaxel, and Carboplatin in Treating Women With Stage II or Stage III Breast Cancer | completed | Phase 2 | 45 | Severance HospitalOTHER | 1 | Apr 10, 2012 | clinicaltrials |
| NCT01437865 | Gadofosveset for Axillary Staging in Breast Cancer Patients | completed | N/A | 10 | Maastricht University Medical CenterOTHER | 1 | Apr 6, 2012 | clinicaltrials |
| NCT00670878 | Studying the Benefits of Adjuvant Sequential vs. Combined Taxane Based Chemotherapy, Followed by Different Biological Treatment Strategies in Early, HER2-positive Breast Cancer | completed | Phase 3 | 799 | Ludwig-Maximilians - University of MunichOTHER | 1 | Apr 3, 2012 | clinicaltrials |
| NCT00717015 | Tamoxifen Pharmacokinetics and CYP2D6 Polymorphisms in Asian Women With Hormone Receptor Positive Breast Cancer | completed | — | — | National University Hospital, SingaporeOTHER | 1 | Apr 3, 2012 | clinicaltrials |
| NCT00991978 | VEGF Early Imaging for Breast Cancer | completed | Early Phase 1 | 23 | University Medical Center GroningenOTHER | 1 | Mar 30, 2012 | clinicaltrials |
| NCT00020098 | Complementary or Alternative Medicine Practices Used by Women at Increased Risk for Breast Cancer | completed | N/A | — | National Institutes of Health Clinical Center (CC)NIH | 1 | Mar 29, 2012 | clinicaltrials |
| NCT00265655 | Satraplatin for Patients With Metastatic Breast Cancer (MBC) | completed | Phase 2 | 40 | AgennixINDUSTRY | 1 | Mar 28, 2012 | clinicaltrials |
Data updated 24 days agoSource updated Jun 14, 2012source: clinicaltrials